147 related articles for article (PubMed ID: 29343677)
1. Prognostic Factors in Glioblastoma: Is There a Role for Epilepsy?
Dobran M; Nasi D; Chiriatti S; Gladi M; Somma LD; Iacoangeli M; Scerrati M
Neurol Med Chir (Tokyo); 2018 Mar; 58(3):110-115. PubMed ID: 29343677
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
4. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.
Gutenberg A; Bock HC; Reifenberger G; Brück W; Giese A
Acta Neurochir (Wien); 2013 Mar; 155(3):429-35. PubMed ID: 23254891
[TBL] [Abstract][Full Text] [Related]
5. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis.
Minniti G; Scaringi C; Lanzetta G; Terrenato I; Esposito V; Arcella A; Pace A; Giangaspero F; Bozzao A; Enrici RM
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):109-15. PubMed ID: 25442339
[TBL] [Abstract][Full Text] [Related]
6. The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study.
Rapp M; Goeppert M; Felsberg J; Steiger HJ; Sabel M
Br J Neurosurg; 2013 Aug; 27(4):430-5. PubMed ID: 23418781
[TBL] [Abstract][Full Text] [Related]
7. Epileptic features and survival in glioblastomas presenting with seizures.
Toledo M; Sarria-Estrada S; Quintana M; Maldonado X; Martinez-Ricarte F; Rodon J; Auger C; Aizpurua M; Salas-Puig J; Santamarina E; Martinez-Saez E
Epilepsy Res; 2017 Feb; 130():1-6. PubMed ID: 28073027
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
9. Interdisciplinary treatment of glioblastoma: analysis of prognostic factors and treatment results in unselected patients.
Langsenlehner T; Groll MJ; Quehenberger F; Payer F; Mokry M; Kapp KS
Neoplasma; 2012; 59(6):662-8. PubMed ID: 22862166
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of epilepsy in glioblastomas.
Toledo M; Sarria-Estrada S; Quintana M; Maldonado X; Martinez-Ricarte F; Rodon J; Auger C; Salas-Puig J; Santamarina E; Martinez-Saez E
Clin Neurol Neurosurg; 2015 Dec; 139():166-71. PubMed ID: 26489387
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of epilepsy at presentation in glioblastoma patients.
Berendsen S; Varkila M; Kroonen J; Seute T; Snijders TJ; Kauw F; Spliet WG; Willems M; Poulet C; Broekman ML; Bours V; Robe PA
Neuro Oncol; 2016 May; 18(5):700-6. PubMed ID: 26420896
[TBL] [Abstract][Full Text] [Related]
12. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
[TBL] [Abstract][Full Text] [Related]
13. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients.
Stark AM; van de Bergh J; Hedderich J; Mehdorn HM; Nabavi A
Clin Neurol Neurosurg; 2012 Sep; 114(7):840-5. PubMed ID: 22377333
[TBL] [Abstract][Full Text] [Related]
15. Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide.
Saito T; Sugiyama K; Ikawa F; Yamasaki F; Ishifuro M; Takayasu T; Nosaka R; Nishibuchi I; Muragaki Y; Kawamata T; Kurisu K
World Neurosurg; 2017 Jan; 97():21-26. PubMed ID: 27693246
[TBL] [Abstract][Full Text] [Related]
16. Evolution of the Karnosky Performance Status throughout life in glioblastoma patients.
Sacko A; Hou MM; Temgoua M; Alkhafaji A; Marantidou A; Belin C; Mandonnet E; Ursu R; Doridam J; Coman I; Levy-Piedbois C; Carpentier AF
J Neurooncol; 2015 May; 122(3):567-73. PubMed ID: 25700836
[TBL] [Abstract][Full Text] [Related]
17. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
Lombardi G; Pace A; Pasqualetti F; Rizzato S; Faedi M; Anghileri E; Nicolotto E; Bazzoli E; Bellu L; Villani V; Fabi A; Ferrazza P; Gurrieri L; Dall'Agata M; Eoli M; Della Puppa A; Pambuku A; D'Avella D; Berti F; Rudà R; Zagonel V
J Neurooncol; 2015 Nov; 125(2):359-67. PubMed ID: 26423801
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
19. A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study.
Illic R; Somma T; Savic D; Frio F; Milicevic M; Solari D; Nikitovic M; Lavrnic S; Raicevic S; Milosevic S; Cavallo LM; Cappabianca P; Grujicic D
World Neurosurg; 2017 Aug; 104():581-588. PubMed ID: 28522381
[TBL] [Abstract][Full Text] [Related]
20. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]